The medical records oj 787 patients admitted with a diagnosis oj viral croup between January 1986 and December 1992 were examined. The study was prompted by an observed change in the pattern oj admissions to the intensive care unit at a large district hospital during the late 1980s. Changes in the pattern oj use oj adrenaline and steroids were noted.
Acute viral laryngotracheobronchitis (croup) is a common cause of upper airway obstruction in young children. This obstruction, caused by oedema of the subglottic region, may become severe and necessitate admission to an Intensive Care Unit and, in some cases, intubation.
Throughout the 1980s a steady increase occurred in the annual number of croup admissions to the intensive care unit at Gosford Hospital, a 475-bed district hospital. This was attributed to an influx of young families into the Central Coast during this period.
The number of patients presenting with croup to the Accident and Emergency Department had been slowly increasing over the years, with the largest number in 1992 (Table 1 ). The changing pattern of admission to the Intensive Care Unit from 1986 to 1992 and the reduction in intubations for severe croup during this period prompted an examination of the available data. It was considered unlikely that the observed decrease in the intubation rate was a chance event, given the increasing number of children presenting to the accident and emergency department with croup during this period.
Since 1981 there have been 160 admissions to in-tensive care with the diagnosis of croup and no patient has died. The use of nebulised adrenaline and parenteral steroids in these children had initially been controversial, and the doses and methods of administration had changed over the years at this hospital, so it was decided to examine in detail the medical files of all hospital admissions for croup between 1986 and 1992 inclusive. The aim of the investigation was to establish a profile of patients admitted with croup and to examine the pattern of use of both steroids and nebulised adrenaline over the years of the study.
MATERIALS AND METHODS
The hospital's Medical Records Department provided the files of all patients admitted with the diagnosis of "croup" from 1986 to 1992 inclusive. The data noted from the files of the 787 patients included age, sex, time of admission, weight in kilograms, temperature in degrees Celsius, duration of admission, month of admission, use of steroids and adrenaline, need for intensive care admission, need for intubation, use of antibiotics and history of previous admission. The results of this examination were collated in a database for analysis.
Medical records were only included in this study if it was clear that the patients had suffered from upper respiratory tract infection immediately prior to presentation to hospital. The infection was presumed to be viral in origin (by exclusion) and required a history of fever, cough or rhinorrhoea together with inspiratory stridor. Medical records coded for croup were carefully checked for accuracy of diagnosis and patients with concomitant bacterial infections such as epiglottitis or tracheitis were excluded. Patients whose records showed a history of previous admission for croup, with or without intubation, asthma or spasmodic croup, were accepted for the study.
Descriptive statistics and data analysis were performed using Statview 11 software on a Macintosh personal computer.
RESULTS
A total of 787 medical records were examined. The average age of the patients with a diagnosis of croup was 2.65 years (± 2 years). The minimum age was three months and the maximum was 12 years. The average age of children who had been previously admitted for croup was slightly greater at 3.6 years (± 2.4 years). This group represented 11070 of the total.
Of all admissions for croup, 575 (73070) were male and 212 (27070) were female. The average axillary temperature at the time of admission was 37.3 degrees Celsius, with a standard deviation of 0.9 degree Celsius. The minimum temperature was 35.6 and the maximum 40.0 degrees Celsius. The majority of admissions were brief, with an average duration just under 2 days (1.7 ± 1.1).
Forty percent of all croup admissions occurred during the autumn months, followed by 28070 in the winter months: 73070 of all admissions occurred rAil!." I Croup adlllissions 1986--1992 
between 6 pm and 6 am. Fifty-six patients (7070) had intravenous infusions and 49 (6070) were commenced on an antibiotic. The use of nebulised adrenaline increased during the period of the study ( Table 2 ). The average dose of nebuIised adrenaline per kilogram also increased ( Table  2 ). There was a significant negative correlation (P < .0001) between the initial dose of nebulised adrenaline and the need to repeat the dose of nebulised adrenaline. However, this significance was weak, accounting for only 15070 of the observed variance.
The use of oral and parenteral steroids increased during the period of {he study (Figure 1) . The use of parental dexamethasone, together with the increasing average dose in milligrams per kilogram, is shown ( 
DISCUSSION
This retrospective survey was prompted by an observation that the pattern of admissions to a district hospital intensive care unit (ICU) for patients with viral laryngotracheobronchitis (croup) had changed. In the early years of the past decade children with moderate \fllIl'\lhniu ami Iflf('mi\'(' Care, "'()1. 22, , .... '0. 2 . . ,1pnl, 1994 to severe croup were admitted to the ICU, placed in a mist tent and closely observed, usually with intravenous hydration. The majority would recover, while a small number would continue to deteriorate and need intubation. The trauma involved for all concerned was considerable. Ten years later children with croup are only occasionally admitted to the ICU, almost invariably a dose of steroid (oral or parenteral) will have been administered and about one-third will have had nebulised adrenaline by facemask. Mist tents are no longer used, virtually all recover within twenty-four hours and in the past four years only one child has required intubation. Given the increasing number of children admitted to this district hospital with croup ( Figure 1) one would have expected an associated increase in the incidence of deterioration and intubation. It would appear that the increased use of steroids and nebulised adrenaline in these patients had been asociated with a reduction in the severity of the illness.
It is of interest to follow over the past ten years the development of management strategies for the treatment of croup. For example, the increase in admissions to ICU for croup during 1988-1990 (Table  1 ) was out of concern that all children given nebulised adrenaline should be admitted to ICU in case of relapse or treatment failure. Experience has since shown that this was not necessary. The variation in dosage for both nebulised adrenaline and steroids was due to differing prescribing patterns of the physicians involved but the trends are obvious (Tables 2 and 3 ). At this hospital a set of guidelines which appears popular throughout Australasia is now used to treat moderate to severe croup: nebulised adrenaline 1:1,000 (0.5 mllkg, maximum dose 5 ml) and parenteral dexamethasone 0.6 mg/kg or prednisolone 2 mg/kg. Also of interest is a comparison of the incidence of steroid administration in the treatment of croup at different hospitals. A study by Sendi, Crysdale and Yoo I at the Hospital for Sick Children in Toronto examined the charts of 377 admissions for croup during 1985 and 1986 and observed that 4.5070 were given parenteral steroids. In 1985 and 1986 at this district hospital steroids were rarely used in the treatment of croup, although this was to change (Table 3 ). By 1992 the Canadian Paediatric Society had developed a policy2 recommending that a single parenteral dose of 0.6 mg/kg of dexamethasone be given to children admitted to hospital with severe croup.
The results of a meta-analysis by Kairys, Olmstead and O'Connor' supported the use of steroids in the treatment of croup and these authors stressed the need for an appropriately "large" dose. Our observations ( Figure 1 and Table 3 ) lend some weight to the argument that an increase in the dose and overall usage of steroids in the treatment of croup results in a reduction of morbidity. The dose of dexamethasone, or its equivalent as prednisone, prednisolone and occasionally hydrocortisone, increased over the years of the survey, While no attempt is made to claim a significant relationship between the use of these agents and the observed reduction in the rate of intubation, there does appear to be qualitative benefit from their usage. The 0,6 mg/kg dose of dexamethasone recommended by Super et aL 4 is currently used at this hospitaL In 199287.5% of croup admissions received a dose of steroid.
The evolution of the use of nebulised adrenaline in the treatment of croup has also been controversiaL Contentious issues regarding dose, frequency of administration, ICU admission criteria and indications for intubation have all been the subject of debate at this institution. In the early 1980s it was said that nebulised adrenaline did not work or resulted in severe relapse and that children requiring repeat doses would have to be intubated. Experience has shown that the dose of nebulised adrenaline is important and initial reluctance to use larger doses probably contributed to the impression that this was an ineffective form of treatment for croup. The initial dose of 0.5 mllkg of 1:1,000 up to a maximum of 5 ml was repeated as often as necessary; however, the need for repeat dosage did decrease ( Table 2) , especially when the patient was also given a dose of steroid. It was not possible to clearly separate the clinical effects of two drugs when given simultaneously and clearly the observed reduction in admissions to ICU and intubation rate for croup at this hospital over the years of the study may be attributed to other factors. There does, however, appear to be good reason to argue that an appropriate dose of nebulised adrenaline in a child with moderate to severe croup will "buy time" while an appropriate dose of steroid acts to reduce subglottic oedema.
The use of steroids and nebulised adrenaline in the treatment of croup is still debated. While there is a scarcity of "hard" data to support the efficacy of these agents in the management of croup, it is likely that most intensivists who regularly manage these children would endorse their use. This retrospective review of the notes of 787 children admitted with croup to a district hospital demonstrated an increase in both dose and frequency of use of steroids and nebulised adrenaline over a seven-year period. This had been associated with a concomitant reduction in the intubation rate and rate of admission to the ICV. There appears to be good reason to use these agents early and aggressively in the treatment of moderate to severe croup.
